ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,579Medicare Part D Prescriptions Filled, Including Refills

Rank: 62 out of 789

$1.52M Total Retail Price of All Prescriptions

Rank: 26 out of 789

559 Patients Receiving at Least One Drug in Part D
68% Patients 65 Years and Older
79% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Alabama
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

16% of this provider’s 559 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

34% of this provider’s 559 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

46 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Alabama
HYDROCODONE-ACETAMINOPHEN 1,230 573 171 S3 1 1
LISINOPRIL 548 349 86 2 6
LEVOTHYROXINE SODIUM 546 387 88 3 3
SIMVASTATIN 543 393 86 4 5
CYMBALTA 536 364 52 5 50
NAMENDA 533 485 46 6 44
OMEPRAZOLE 508 318 81 7 2
FUROSEMIDE 442 310 96 8 7
GABAPENTIN 436 286 82 9 11
AMLODIPINE BESYLATE 432 349 53 10 4
OXYCODONE HCL 406 123 47 S2 11 112
ALPRAZOLAM 384 182 52 B 12 13
CARVEDILOL 355 280 61 13 16
METFORMIN HCL 305 171 51 14 9
PANTOPRAZOLE SODIUM 292 232 50 15 19
WARFARIN SODIUM 291 252 36 16 27
CLONAZEPAM 288 111 41 B 17 29
DONEPEZIL HCL 284 269 47 18 39
CLOPIDOGREL 266 223 39 19 23
PROMETHAZINE HCL 255 70 54 R 20 80
POTASSIUM CHLORIDE 247 185 45 21 14
MIRTAZAPINE 247 207 60 21 58
HYDROCHLOROTHIAZIDE 241 152 40 23 15
ZOLPIDEM TARTRATE 241 109 42 23 21
RANITIDINE HCL 236 158 33 25 49
TRAMADOL HCL 232 158 56 26 17
MONTELUKAST SODIUM 222 113 40 27 40
CELEBREX 218 176 26 28 82
ROPINIROLE HCL 213 150 35 29 86
METOPROLOL SUCCINATE 213 126 37 29 20
CITALOPRAM HBR 211 140 34 31 25
CRESTOR 205 166 30 32 38
TAMSULOSIN HCL 204 123 35 33 36
LORAZEPAM 198 122 41 B 34 37
MELOXICAM 189 105 38 35 18
NEXIUM 188 101 34 36 24
METOPROLOL TARTRATE 185 112 31 37 22
ATORVASTATIN CALCIUM 184 125 44 38 8
LAMOTRIGINE 184 127 19 38 210
FENOFIBRATE* 184 100 31 38 60
LYRICA 180 90 25 41 51
SPIRONOLACTONE 177 113 30 42 56
SERTRALINE HCL 175 110 17 43 28
TRAZODONE HCL 171 91 34 44 33
ISOSORBIDE MONONITRATE ER 165 135 26 45 70
QUETIAPINE FUMARATE 164 127 20 A 46 66
DIAZEPAM 162 71 28 B 47 91
VENLAFAXINE HCL ER 161 106 25 48 96
VESICARE 159 105 15 49 153
TIZANIDINE HCL 158 61 36 50 67
TOPIRAMATE 157 53 23 51 136
AZITHROMYCIN 146 84 99 52 47
CARISOPRODOL 144 <11 14 R 53 85
METHYLPREDNISOLONE 144 82 109 53 84
LOSARTAN POTASSIUM 140 103 27 55 12
ALLOPURINOL 132 93 20 56 34
FLUTICASONE PROPIONATE 130 61 45 57 41
RAMIPRIL 127 93 23 58 72
ATENOLOL 127 98 19 58 26
SPIRIVA 126 78 21 60 76
PRAVASTATIN SODIUM 123 94 23 61 10
TEMAZEPAM 121 84 19 B 62 77
METHADONE HCL 121 30 12 S2 62 144
PROAIR HFA 121 33 32 62 48
METOCLOPRAMIDE HCL 115 82 21 65 115
CLONIDINE HCL 114 62 25 66 35
MECLIZINE HCL 110 91 27 67 83
LANTUS 103 75 21 68 89
PREDNISONE 102 67 31 69 46
LISINOPRIL-HYDROCHLOROTHIAZIDE 101 66 21 70 30
EXELON 99 94* 20 71 142
GLIMEPIRIDE 97 57 17 72 32
DEXILANT 88 <11 <11 73 207
SULFAMETHOXAZOLE-TRIMETHOPRIM 88 55 60 73 90
NOVOLOG 88 52 19 73 178
MORPHINE SULFATE ER 87 40 15 S2 76 156
ESCITALOPRAM OXALATE 87 59 16 76 42
FINASTERIDE 86 81* 15 78 129
ZETIA 85 46 14 79 79
DIOVAN 84 66 12 80 65
BUSPIRONE HCL 84 68 18 80 109
FLUOXETINE HCL 82 49 13 82 64
HYDRALAZINE HCL 80 47 16 83 57
HYDROXYZINE HCL 78 42 20 R 84 182
AGGRENOX 76 <11 <11 85 232
PHENYTOIN SODIUM EXTENDED 74 <11 <11 86 147
OXYCONTIN 73 42 11 S2 87 177
RISPERIDONE 72 <11 <11 A 88 106
METOLAZONE 72 67* 15 88 206
HYDROCODONE BIT-IBUPROFEN 72 41 18 S3 88 200
AMOXICILLIN 71 31 55 91 97
LEVEMIR 70 <11 <11 92 195
FLUCONAZOLE 68 34 32 93 108
DIGOX 66 <11 <11 94 93
POLYETHYLENE GLYCOL 3350 66 40 20 94 87
LIDODERM 65 36 15 96 253
BENAZEPRIL HCL 64 <11 <11 97 68
OLANZAPINE 63 <11 <11 A 98 172
CARBIDOPA-LEVODOPA 61 <11 <11 99 155
BD ULTRA-FINE PEN NEEDLE 61 44 22 99 111
LOSARTAN-HYDROCHLOROTHIAZIDE 61 47 14 99 31
NAPROXEN 60 34 11 102 98
NYSTATIN 59 48 24 103 193
PRIMIDONE 57 <11 <11 104 215
ULORIC 57 <11 <11 104 312
CYCLOBENZAPRINE HCL 56 18 12 R 106 53
AMLODIPINE BESYLATE-BENAZEPRIL 56 <11 <11 106 54
XIFAXAN 55 <11 <11 108 453
LOVAZA 53 33 11 109 164
ALBUTEROL SULFATE 53 48* 25 109 204
BUPROPION XL 53 <11 <11 109 139
QUINAPRIL HCL 53 <11 <11 109 120
PRAMIPEXOLE DIHYDROCHLORIDE 52 <11 <11 113 149
ADVAIR DISKUS 52 <11 <11 113 71
SAVELLA 51 <11 <11 115 404
SUCRALFATE 50 23 15 116 140
TRIAMTERENE-HCTZ 50 <11 <11 116 43
OXYCODONE HCL-ACETAMINOPHEN 50 <11 <11 S2 116 101
LEVETIRACETAM 50 <11 <11 116 122
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 26, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.